Kinase activity of protein kinase Cα in serum as a diagnostic biomarker of human lung cancer

Jeong Hun Kang, Takeshi Mori, Hirotaro Kitazaki, Takuro Niidome, Koichi Takayama, Yoichi Nakanishi, Yoshiki Katayama

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: Recently, we reported on the existence of activated protein kinase Cα (PKCα) in blood and the possibility for its use in cancer diagnosis. Materials and Methods: In the present study, serum samples collected from patients with different lung cancer types (small-cell cancer, adenocarcinoma, and anaplastic cancer) were phosphorylated with a PKCα-specific peptide substrate and the phosphorylation ratio was detected by matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry. Results: When 13 patient serum samples were phosphorylated with peptide substrates, phosphorylated peaks were obtained in eight samples. However, no peak associated with the phosphorylated peptide was observed using serum samples obtained from 10 healthy persons. Moreover, broadly used cancer biomarkers (progastrin-releasing peptide, carcinoembryonic antigen, and cytokeratin-19 fragment) were identified in eight samples among the 13 samples studied. Conclusion: These results suggest that serum activated PKCα is a reliable biomarker, applicable to lung cancer diagnosis.

Original languageEnglish
Pages (from-to)485-488
Number of pages4
JournalAnticancer research
Volume33
Issue number2
Publication statusPublished - Feb 1 2013

Fingerprint

Lung Neoplasms
Biomarkers
Protein Kinase C
Peptides
Serum
Keratin-19
Neoplasms
Carcinoembryonic Antigen
Small Cell Lung Carcinoma
Tumor Biomarkers
Blood Proteins
Mass Spectrometry
Adenocarcinoma
Lasers
Phosphorylation
protein kinase C kinase

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Kang, J. H., Mori, T., Kitazaki, H., Niidome, T., Takayama, K., Nakanishi, Y., & Katayama, Y. (2013). Kinase activity of protein kinase Cα in serum as a diagnostic biomarker of human lung cancer. Anticancer research, 33(2), 485-488.

Kinase activity of protein kinase Cα in serum as a diagnostic biomarker of human lung cancer. / Kang, Jeong Hun; Mori, Takeshi; Kitazaki, Hirotaro; Niidome, Takuro; Takayama, Koichi; Nakanishi, Yoichi; Katayama, Yoshiki.

In: Anticancer research, Vol. 33, No. 2, 01.02.2013, p. 485-488.

Research output: Contribution to journalArticle

Kang, JH, Mori, T, Kitazaki, H, Niidome, T, Takayama, K, Nakanishi, Y & Katayama, Y 2013, 'Kinase activity of protein kinase Cα in serum as a diagnostic biomarker of human lung cancer', Anticancer research, vol. 33, no. 2, pp. 485-488.
Kang JH, Mori T, Kitazaki H, Niidome T, Takayama K, Nakanishi Y et al. Kinase activity of protein kinase Cα in serum as a diagnostic biomarker of human lung cancer. Anticancer research. 2013 Feb 1;33(2):485-488.
Kang, Jeong Hun ; Mori, Takeshi ; Kitazaki, Hirotaro ; Niidome, Takuro ; Takayama, Koichi ; Nakanishi, Yoichi ; Katayama, Yoshiki. / Kinase activity of protein kinase Cα in serum as a diagnostic biomarker of human lung cancer. In: Anticancer research. 2013 ; Vol. 33, No. 2. pp. 485-488.
@article{fa2e316b073b439fba0222730987dcfe,
title = "Kinase activity of protein kinase Cα in serum as a diagnostic biomarker of human lung cancer",
abstract = "Background: Recently, we reported on the existence of activated protein kinase Cα (PKCα) in blood and the possibility for its use in cancer diagnosis. Materials and Methods: In the present study, serum samples collected from patients with different lung cancer types (small-cell cancer, adenocarcinoma, and anaplastic cancer) were phosphorylated with a PKCα-specific peptide substrate and the phosphorylation ratio was detected by matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry. Results: When 13 patient serum samples were phosphorylated with peptide substrates, phosphorylated peaks were obtained in eight samples. However, no peak associated with the phosphorylated peptide was observed using serum samples obtained from 10 healthy persons. Moreover, broadly used cancer biomarkers (progastrin-releasing peptide, carcinoembryonic antigen, and cytokeratin-19 fragment) were identified in eight samples among the 13 samples studied. Conclusion: These results suggest that serum activated PKCα is a reliable biomarker, applicable to lung cancer diagnosis.",
author = "Kang, {Jeong Hun} and Takeshi Mori and Hirotaro Kitazaki and Takuro Niidome and Koichi Takayama and Yoichi Nakanishi and Yoshiki Katayama",
year = "2013",
month = "2",
day = "1",
language = "English",
volume = "33",
pages = "485--488",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "2",

}

TY - JOUR

T1 - Kinase activity of protein kinase Cα in serum as a diagnostic biomarker of human lung cancer

AU - Kang, Jeong Hun

AU - Mori, Takeshi

AU - Kitazaki, Hirotaro

AU - Niidome, Takuro

AU - Takayama, Koichi

AU - Nakanishi, Yoichi

AU - Katayama, Yoshiki

PY - 2013/2/1

Y1 - 2013/2/1

N2 - Background: Recently, we reported on the existence of activated protein kinase Cα (PKCα) in blood and the possibility for its use in cancer diagnosis. Materials and Methods: In the present study, serum samples collected from patients with different lung cancer types (small-cell cancer, adenocarcinoma, and anaplastic cancer) were phosphorylated with a PKCα-specific peptide substrate and the phosphorylation ratio was detected by matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry. Results: When 13 patient serum samples were phosphorylated with peptide substrates, phosphorylated peaks were obtained in eight samples. However, no peak associated with the phosphorylated peptide was observed using serum samples obtained from 10 healthy persons. Moreover, broadly used cancer biomarkers (progastrin-releasing peptide, carcinoembryonic antigen, and cytokeratin-19 fragment) were identified in eight samples among the 13 samples studied. Conclusion: These results suggest that serum activated PKCα is a reliable biomarker, applicable to lung cancer diagnosis.

AB - Background: Recently, we reported on the existence of activated protein kinase Cα (PKCα) in blood and the possibility for its use in cancer diagnosis. Materials and Methods: In the present study, serum samples collected from patients with different lung cancer types (small-cell cancer, adenocarcinoma, and anaplastic cancer) were phosphorylated with a PKCα-specific peptide substrate and the phosphorylation ratio was detected by matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry. Results: When 13 patient serum samples were phosphorylated with peptide substrates, phosphorylated peaks were obtained in eight samples. However, no peak associated with the phosphorylated peptide was observed using serum samples obtained from 10 healthy persons. Moreover, broadly used cancer biomarkers (progastrin-releasing peptide, carcinoembryonic antigen, and cytokeratin-19 fragment) were identified in eight samples among the 13 samples studied. Conclusion: These results suggest that serum activated PKCα is a reliable biomarker, applicable to lung cancer diagnosis.

UR - http://www.scopus.com/inward/record.url?scp=84875891200&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875891200&partnerID=8YFLogxK

M3 - Article

C2 - 23393340

AN - SCOPUS:84875891200

VL - 33

SP - 485

EP - 488

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 2

ER -